Necrotizing Gingivostomatitis Treatment Market Share

  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Necrotizing Gingivostomatitis Treatment Market Share

North American Market Forecast

The market share of necrotizing gingivostomatitis treatment in North America, amongst the market in all the other regions, is projected to be the largest with a share of about 39% by the end of 2036. The growth of the market can be attributed majorly to the high prevalence of lifestyle diseases, caused by inactive routines, busy lifestyles, and unhealthy eating habits. According to data from the Centers for Disease Control and Prevention, over 45% of Americans suffer from at least one chronic disease in the U.S. The increasing preference for outside food and a growing number of people eating ready-made and fast foods owing to the growing working population is estimated to propel the market growth in the coming years. Also, an improper diet with no nutrients is estimated to drive market growth. The increasing number of people consuming spicy foods that do not contain any nutritional value is estimated to boost the market growth. Intake of food with no proper proteins or vitamins and increasing changes in eating habits also drive the market growth.  

Europe Market Forecast

The European necrotizing gingivostomatitis treatment market is estimated to be the second largest, registering a share of about 22% by the end of 2036. The growth of the market can be attributed majorly to the largely Caucasian population, and the poor lifestyle of the people in developed nations. Over 50 million people in Europe suffer from chronic conditions. The rising number of people suffering from immune suppressive disorders across the region owing to aging and genetic disorders is estimated to drive the growth of the market. Unhygienic healthcare habits such as not washing hands after using restrooms are also estimated to propel the market growth in the coming years. Increasing preference for fast foods as they taste good and do not require much time for preparation as more people started working jobs is also estimated to drive the market growth during the forecast period. Also, the market growth is attributed to many people in the region suffering from periodontitis with increasing incidence in the elder population. The cost of oral health services is very high in the region which is estimated to drive the market growth.

APAC Market Statistics

Further, the market in the Asia Pacific, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2036. The growth of the market can be attributed majorly to the rising dehydration among people owing to a lack of concentration on health and more involvement in work. The growing number of people with mouth ulcers and blisters caused by stress and sleep deprivation is expected to fuel the market growth. The increasing number of people suffering from gum diseases owing to the lack of education in some countries leads to the development of serious infections causing gingivostomatitis which is estimated to hike the market growth. Also, using the same razors unknowingly by local barber shops and the same makeup products by beauticians increases the chances of disease occurrence which in turn propels the market growth. The lack of government programs to educate the slum areas about the complications caused by not washing hands after using public toilets is estimated to propel the market growth.

Research Nester
Necrotizing Gingivostomatitis Treatment Market Size
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3570
  • Published Date: Jul 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of necrotizing gingivostomatitis treatment is estimated at USD 16.94 Million.

The necrotizing gingivostomatitis treatment market size was valued at USD 15.99 Million in 2023 and is anticipated to cross USD 36.7 Million by the end of 2036, expanding at more than 6.6% CAGR during the forecast period i.e., between 2024-2036. Increasing incidences of necrotizing gingivostomatitis and the rising use of public toilets are the major factors driving the market growth.

North America is poised to be the largest with a share of about 39% by 2036, attributed to high prevalence of lifestyle diseases, caused by inactive routines, busy lifestyles, and unhealthy eating habits.

Novartis International AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd., Abbott Laboratories, Eli Lilly and Company, Hindustan Antibiotics Limited, Aviro Health L.P.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample